TABLE 3.
Summary of TEAEs
| FMX103 1.5% (N=20) | |
|---|---|
| Subjects with any TEAE, n (%) | 1 (5.0) |
| Number of TEAEsa | 2 |
| Subjects with any treatment-related TEAE, n (%) | 1 (5.0) |
| Number of treatment-related TEAEsb | 1 |
| Subjects with any serious TEAE, n (%) | 0 (0.0) |
| Number of serious TEAEs | 0 |
| Subjects with any severe TEAE, n (%) | 0 (0.0) |
| Number of severe TEAEs | 0 |
| Subjects with any TEAE leading to discontinuation, n (%) | 0 (0.0) |
| Number of TEAEs leading to discontinuation | 0 |
TEAE, treatment-emergent adverse event
aArthralgia (moderate severity), headache (mild severity)
bHeadache